ROYAL BANK OF CANADA - AKOYA BIOSCIENCES INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AKOYA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$14,000
+40.0%
3,157
+120.3%
0.00%
Q2 2023$10,000
+11.1%
1,433
+17.7%
0.00%
Q1 2023$9,000
-62.5%
1,217
-51.2%
0.00%
Q4 2022$24,000
+300.0%
2,494
+377.8%
0.00%
Q3 2022$6,000
+20.0%
522
+24.6%
0.00%
Q2 2022$5,000
-58.3%
419
-63.7%
0.00%
Q1 2022$12,000
-71.4%
1,154
-58.4%
0.00%
Q4 2021$42,000
+200.0%
2,773
+160.6%
0.00%
Q3 2021$14,000
+40.0%
1,064
+103.4%
0.00%
Q2 2021$10,0005230.00%
Other shareholders
AKOYA BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,104,785$24,731,0009.98%
Hudson Executive Capital LP 3,697,558$43,446,0006.22%
Altium Capital Management LP 296,000$3,478,0001.28%
Board of Trustees of The Leland Stanford Junior University 774,116$9,096,0000.58%
Parkman Healthcare Partners LLC 161,701$1,900,0000.54%
CLARK ESTATES INC/NY 171,976$2,021,0000.45%
Granahan Investment Management 398,824$4,686,0000.15%
Uniplan Investment Counsel, Inc. 167,709$1,970,0000.15%
RTW INVESTMENTS, LP 483,815$5,685,0000.13%
OSTERWEIS CAPITAL MANAGEMENT INC 126,131$1,482,0000.11%
View complete list of AKOYA BIOSCIENCES INC shareholders